A5078195802- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Infectious Diseases and Tuberculosis
- CAR-T cell therapy research
- Sepsis Diagnosis and Treatment
- Heparin-Induced Thrombocytopenia and Thrombosis
- Prostate Cancer Treatment and Research
- Mesenchymal stem cell research
- Venous Thromboembolism Diagnosis and Management
- Renal and related cancers
- Cancer, Lipids, and Metabolism
- Economic and Financial Impacts of Cancer
- Pancreatic and Hepatic Oncology Research
- Respiratory Support and Mechanisms
- Cancer Immunotherapy and Biomarkers
- Radiopharmaceutical Chemistry and Applications
- Genetic factors in colorectal cancer
- Renal cell carcinoma treatment
Azienda Ospedaliero-Universitaria di Modena
2015-2023
University of Modena and Reggio Emilia
2015-2020
Ospedale Vito Fazzi
2005
University of Salento
2005
Aims: This retrospective study aimed to investigate safety and efficacy of everolimus in patients with metastatic renal cell carcinoma (mRCC) end-stage disease requiring dialysis. Patients & methods: From November 2009 December 2012, 11 mRCC undergoing dialysis were treated after failure anti-VEGF therapy at six Italian institutions. Patient characteristics, outcomes collected. Results: Progression-free survival overall determined using the Kaplan–Meier method. Median progression-free 9.01...